Advanced Therapy Medicinal Product Interest Group

The purpose of the Advanced Therapy Medicinal Product (ATMP) Interest Group (IG) is to bring together professionals who steward novel therapeutic products toward commercialization. The group is focused on the unique challenges faced in the development and commercialization of cell and gene therapy products. Collaboration is essential, given the nature of these products, the evolving science, and the need for clarity in the application of GMPs. Members openly discuss their issues and concerns, lessons learned, and best practices. Considering the strong academic base of knowledge for these products, this group provides PDA with collaborative guidance that can benefit the patient community. The group shares insights into new, advanced manufacturing techniques, experimental approaches to address the challenges of lifecycle management, scientific thinking related to standards and standardization, and commercialization efforts of maturing companies within the space. This group and all other PDA Interest Groups are designed to spark information exchange, actionable solutions and networking among peers who have shared challenges and interests. 

• Click the “Join this Interest Group” button below and click the “Join” button for the IGs you wish to receive communications from regarding virtual meetings, special events, and volunteer opportunities.


• The Interest Group LinkedIn Group is open to anyone interested in the topics and provides an online venue to meet experts and to engage in group discussions and learn about valuable PDA resources. Click the “Follow Discussion” button below and request to join.


• Virtual and in-person meetings are scheduled throughout the year. Virtual meetings are exclusively for active PDA members. In-person meetings, often held in conjunction with PDA’s signature conferences, are open to any conference attendee.